Kunihiko Ito1, Noriko Kobayashi, Yoko Nagata
1Department of Research, Research Institute of Tuberculosis, JATA, Tokyo, Japan. ito@jata.or.jp
Many tuberculosis (TB) advisory committees are not adequately assessing TB treatments, often lacking crucial drug sensitivity information. Reforms are urgently needed to improve TB control and combat drug-resistant tuberculosis.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: